Gus Carey, the founder of Allergy Technologies, came into the business of bed bugs in an unconventional way. With roots in the financial services industry, Mr. Carey founded Allergy Technologies in 2001, with a commitment to manufacture innovative, effective and consumer-friendly products to address issues impacting the environment and healthcare.
After seeing the positive impact of ActiveGuard® liners on the lives of asthmatics, Mr. Carey was alerted by a state regulator to the significant potential for the active liners to help people wrestling with the physical and emotional effects of bed bugs. Today, hotel chains, apartment owners and pest management professionals are recommending the product for its effectiveness and ease of use.
Mr. Carey is focused on ensuring that ActiveGuard® product claims are based on the result of scientific truth and rigor, and in addition to the company’s Board of Directors, he has also assembled an outstanding group of scientific advisors and business advisors. Allergy Technologies is now the second largest funder of bed bug research in the United States.
Allergy Technologies is a “Philanprofit” company, and its managers and employees are expected to be stewards of the community and environment, making meaningful contributions to local, state and national philanthropic causes. Consistent with that spirit, a portion of all Allergy Technologies profits are dedicated to improving the lives of others.
Before his work with Allergy Technologies, Mr. Carey was a Managing Director of W.P. Carey & Co. (NYSE:WPC) and Vice Chairman and President of four publicly-offered REITs sponsored by W. P. Carey, with assets totaling over $2-billion. He has also served as a loan officer in the North American Department of Kleinwort Benson Limited in London and was Controller at ETA Computer Services.
Mr. Carey has an A.B. in Asian Studies from Amherst College, a Master’s degree in Management Studies from Oxford University, and a degree in Advanced Management from Harvard University.
Mr. Carey is a former Chairman of the Corporate Advisory Council for the Financial Planning Association and of the Investment Program Association in Washington. A former Board Member of Miss Porter’s School, Springside School (Chair of Development Committee) and the Highlands Mansion and Gardens (Treasurer), Mr. Carey is currently on the Board of the Philadelphia Zoo and is a member of the Board of Visitors at the Ambler Campus of Temple University.
He lives in Ambler with his wife, Jenny Rose Carey, Director of PHS Meadowbrook Farms. They have three daughters; Meade, Janet and Emily.
Joseph S. Latino has over 20 years’ experience in the overlapping fields of science and pest control. As President of Allergy Technologies, he oversees the market expansion of the company’s proprietary fabric-based technology product, ActiveGuard® Mattress Liners, in both current and new markets.
Mr. Latino also oversees business development, strategic market planning, key account management, retention, sales team management, merchandising operations, and contract negotiation.
Before joining Allergy Technologies in 2009, Mr. Latino led the Corporate Development function for Rambug Pest Control for 12 years, overseeing the development and expansion of the company’s client base. During his tenure, he established new service contracts with major property management companies, universities and colleges, and several brand-name retail chains.
As a registered speaker for the New York State/New Jersey Departments of Environmental Control, Mr. Latino continues to develop and refine comprehensive and strategic bed bug surveillance, treatment and post-treatment control programs.
Mr. Latino hails from the scientific world, having served as co-founder and CEO of AcquiSci, a privately-held company whose mission was to identify, acquire and develop undervalued and promising emergent medical technologies.
He has also acted as a consultant and Head of Research for LipidViro Tech, as an extramural consultant for Health Canada, and served as Director of Special Hematology/Oncology Laboratories at The Brooklyn Hospital in New York.
Mr. Latino was doctorally trained as a biochemist at the CUNY Graduate Center in New York, where he earned a Master’s degree in Biochemistry. He holds a Bachelor’s degree in Biology and Chemistry from Brooklyn College.